文献速递心力衰竭与心肌病

心源性休克幸存者的长期预后与康复管理

Survivorship After Cardiogenic Shock.
PubMed 文献 · Circulation · 2025-01-21

综述指出,随着临时机械循环支持和多学科休克团队等重症治疗进展,心源性休克患者出院生存率已达60%至70%。但幸存者出院后可能长期面临心脏及非心脏后遗症,而多数研究仅关注生存,对长期康复指标数据有限。本文识别心源性休克幸存者的独特方面,借鉴其他重症监护后综合征经验,并提出未来研究方向。

要点

  • 心源性休克出院生存率已达60%至70%,但幸存者长期面临心脏和非心脏后遗症。
  • 多数心源性休克研究聚焦生存,长期康复指标数据有限。
  • 借鉴其他重症监护后综合征经验,认知、体能和心理健康损害影响生活质量和预后。

核心结论

  • 心源性休克幸存者出院后可能长期面临心脏及非心脏后遗症,需关注长期康复和幸存者管理。

研究设计与样本

  • 综述,未报告系统检索范围或样本量。

主要发现

  • 心源性休克患者出院生存率范围为60%至70%。
  • 多数心源性休克研究主要关注生存,对幸存者长期康复指标数据有限。
  • 其他重症疾病研究表明,许多ICU幸存者存在认知功能、体能和心理健康等多领域损害,统称重症监护后综合征,影响生活质量和未来预后。

临床怎么用

  • 临床应关注心源性休克幸存者出院后的长期心脏及非心脏后遗症,借鉴重症监护后综合征的康复策略。

局限性

  • 心源性休克幸存者长期康复指标数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%. After their index hospitalization, however, survivors of CS may continue to face cardiac as well as extracardiac sequelae of these therapies and complications for years to come. Most studies in CS have focused primarily on survival, with limited data on long-term recovery measures among survivors. In other forms of critical illness, research indicates that many intensive care unit survivors experience impairments in multiple domains, such as cognitive function, physical ability, and mental health. These impairments, collectively referred to as Post-Intensive Care Syndrome, in turn impact survivors' quality of life and future prognosis. This review identifies unique aspects of CS-related survivorship, highlights lessons learned from other forms of critical illness, and outlines future research directions to determine specific strategies to enhance recovery and survivorship after CS.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Hall, Agarwal, Cullum, et al. Survivorship After Cardiogenic Shock. Circulation. 2025. PMID: 39836757. doi:10.1161/CIRCULATIONAHA.124.068203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。